Skip to main content
Premium Trial:

Request an Annual Quote

Streck, Van Xuan Medical Ink Vietnamese Distribution Deal

NEW YORK (GenomeWeb) – Streck said today that it has inked a three-year agreement for the distribution of its portfolio of controls, cell stabilization, and molecular products by Van Xuan Medical Technology, a provider of medical equipment and reagents to clinical and research laboratories throughout Vietnam.

Financial and other terms of the deal were not disclosed.

Van Xuan's product line consists of medical equipment, analyzers, and high-quality reagents from suppliers in the US and Europe, and its customers include public hospitals and private clinics, and pharma and manufacturing labs, Streck said.

Streck noted that its own portfolio includes control products that test the performance and limits of instruments and reagents, helping laboratories meet regulatory and accreditation requirements.

Streck's molecular products division is focused on the generation of rapid diagnostic tools and includes its Arm-D Kits for the detection of antibiotic resistance genes by multiplex real-time PCR.

And it has several cell stabilization products, including Cyto-Chex BCT, a blood collection tube; Cell-Free DNA BCT, a direct-draw blood collection tube that stabilizes nucleated blood cells and prevents the release of genomic DNA; Cell-Free RNA BCT, a blood collection tube that has a patented preservative that stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage; and Cell-Free DNA Urine Preserve, a liquid reagent that stabilizes cell-free DNA in urine.